Faculty ProfilesRena Fox, MD
1545 Divisadero Street
San Francisco, CA 94115
Dr. Rena Fox is a Professor of Medicine at University of California, San Francisco (UCSF). She has been on the faculty in the Division of General Internal Medicine for 18 years. Dr. Fox was an undergraduate at Stanford, got her MD at UC San Diego and did her internal medicine residency at University of Washington. She was a general medicine fellow at UCSF with an interest in hepatitis C during which time she was trained by UCSF hepatologists in viral hepatitis and since then, Dr. Fox has been the sole faculty member at UCSF who is both an expert in hepatitis C and is a general internist, and is one of the few people in the country in this unique position. Dr. Fox is internationally recognized as an educator – she lectures around the country and she has been working with the Veterans Administration for a decade on hepatitis C educational tools, national policies and as the Medical Editor of the VA Viral Hepatitis Website. As part of the DHHS Hepatitis Action Plan, and the CDC aim to educate the country's physicians in hepatitis C, she is on a national advisory board with the University of Washington, creating an online hepatitis C curriculum for HCV education. She is a co-author and panel member of the clinical practice guidelines for the VA regarding the use of hepatitis C drugs. She served as a clinical expert for the California Technology Assessment Forum (CTAF) meetings on hepatitis C drugs in 2014 and is currently a CTAF voting panel member and Vice Chair. She serves on the faculty of the UCSF Hepatitis C ECHO clinic, providing telemedicine consultation on hepatitis C management for providers in underserved and rural areas. As a researcher, she studies hepatitis C epidemiology and clinical outcomes, including long term outcomes of hepatocellular carcinoma and cirrhosis in large multicenter studies. Dr. Fox trains UCSF medical students and Internal Medicine residents. She sees patients in two settings – she has a large panel of primary care patients at the UCSF General Medicine practice, and she treats hepatitis C patients at the Liver Clinic at UCSF.
Education and Training
|Location||Degree or Training||Specialty||Date|
|UCSF||Clinician-Educator Fellowship||General Internal Medicine||2001|
|University of Washington||Internship and Residency||Internal Medicine||2000|
|University of California San Diego||M.D.||School of Medicine||1997|
|Bryn Mawr College||Post-Baccalaureate||1992|
|Stanford University||B.A.||Human Biology||1991|
Related Web Sites
- Clinical Profile at UCSF Medical Center
- UCSF Division of General Internal Medicine Profile
- Department of Veterans Affairs Viral Hepatitis Website
- CTAF-ICER: California Technology Assessment Forum/Institute for Clinical and Economic Review
- UCSF Hepatitis C Project ECHO
- Hepatitis C Online
In the News
- New Hepatitis C Treatment - "Press Play"
- The Atlantic LIVE
- The New York Times - "New Hepatitis C Drug Soars"
- San Francisco Chronicle - "$1,000 Hepatitis C Pill a Tough Miracle to Swallow"
- Medical Economics "Treating Hepatitis C Means Expanded Role for Primary Care."
- Washington Post - "Cost of New Hepatitis C Drug Ignites Debate."
Recent Articles (16)
Kaplan DE, Chapko MK, Mehta R, Dai F, Skanderson M, Aytaman A, Baytarian M, D'Addeo K, Fox R, Hunt K, Pocha C, Valderrama A, Taddei TH. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2017 Jul 26.
Serper M, Taddei TH, Mehta R, D'Addeo K, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K, Goldberg DS, Valderrama A, Kaplan DE. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality. Gastroenterology. 2017 Jun; 152(8):1954-1964.
Goldberg DS, Taddei TH, Serper M, Mehta R, Dieperink E, Aytaman A, Baytarian M, Fox R, Hunt K, Pedrosa M, Pocha C, Valderrama A, Kaplan DE. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis. Hepatology. 2017 Mar; 65(3):864-874.
Kaplan DE, Dai F, Skanderson M, Aytaman A, Baytarian M, D'Addeo K, Fox R, Hunt K, Knott A, Mehta R, Pedrosa M, Pocha C, Valderrama A, Taddei T. Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis. Dig Dis Sci. 2016 Nov; 61(11):3309-3320.
Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan; 176(1):65-73.
Kaplan DE, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K, Knott A, Pedrosa M, Pocha C, Mehta R, Duggal M, Skanderson M, Valderrama A, Taddei TH. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2333-41.e1-6.
Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol. 2007 Oct; 47(4):527-37.
Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005 Jul 15; 41(2):177-86.